Solution Spotlight: Inventus Control (Mobile Device Management)
Inventus is the only company in the world dedicated to creating purpose-built devices & technology solutions exclusively for clinical trials. Through Inventus Control, the business delivers a dedicated Mobile Device Management (MDM) platform for the life sciences sector.
What problem or status quo deficiency are you solving?
Clinical trials increasingly rely on connected devices to capture data, enable patient engagement, and support decentralised and hybrid study models. However, many organisations continue to manage these devices using generic enterprise or consumer-focused Mobile Device Management (MDM) platforms that were never designed for the unique demands of clinical research.
This creates challenges around compliance, device consistency, security, patient usability, and operational oversight. Sponsors and CROs often find themselves managing multiple vendors, disconnected systems, and complex workflows across countries, languages, and regulatory environments. As studies become larger and more geographically dispersed, these inefficiencies can impact patient experience, increase operational burden, and introduce unnecessary risk. Inventus Control was developed specifically to address these challenges.
As a purpose-built Mobile Device Management platform for clinical trials, it provides sponsors, CROs, and technology partners with a dedicated environment designed around the realities of clinical research. The result is greater visibility, control, compliance, and reliability throughout the device lifecycle, helping studies operate more efficiently while improving the experience for both patients and sites.
What has made this problem challenging to address in the past?
Historically, clinical trials have adapted technologies developed for other industries, rather than benefitting from solutions designed specifically for research. Traditional MDM platforms were built to support corporate workforces, enterprise mobility, or consumer device fleets, not global clinical studies involving patients, investigators, sites, and multiple stakeholders.
Clinical trials present unique requirements that make standard approaches difficult to apply. Devices may be deployed across dozens of countries, multiple regulatory jurisdictions, and hundreds of languages. They often need to be locked down to a specific study configuration, remotely supported, monitored, and maintained while ensuring data security and compliance throughout the process.
In addition, sponsors frequently rely on multiple providers for hardware, connectivity, logistics, support, and device management. This fragmented ecosystem can create gaps in visibility and accountability, making troubleshooting more difficult and increasing operational complexity.
As decentralised and hybrid trials have expanded, these challenges have become even more pronounced. The industry has needed a dedicated approach that treats device management not as an IT function, but as a critical component of clinical trial infrastructure.
What new innovations does your solution bring to bear on these challenges?
Inventus Control represents a shift from generic mobility management to purpose-built clinical trial device management. Rather than adapting enterprise technology to fit clinical research, the platform has been designed specifically around the requirements of sponsors, CROs, sites, and patients.
The platform provides centralised oversight of study devices across their entire lifecycle, from provisioning and deployment through to support, retrieval, refurbishment, and redeployment. Real-time visibility allows stakeholders to monitor device health, connectivity status, battery performance, application compliance, and usage metrics globally.
A key innovation is the integration of device management with the broader Inventus ecosystem, including purpose-built clinical trial devices and global connectivity services. This creates a unified environment where hardware, connectivity, and management operate together, rather than as separate components.
The platform is also designed to support studies at global scale, with deployments across multiple countries, languages, and regulatory environments. By bringing these capabilities together in a single purpose-built solution, Inventus Control helps reduce complexity while increasing operational efficiency, reliability, and study oversight.
How does your solution work?
Inventus Control provides a secure cloud-based management platform that enables sponsors, CROs, and technology partners to oversee clinical trial devices from a single interface. Once devices are enrolled into the platform, administrators gain real-time visibility and control regardless of where those devices are deployed globally.
The platform enables remote configuration, application deployment, policy enforcement, device monitoring, troubleshooting, and software updates. This allows study teams to maintain consistency across large device fleets while reducing the need for manual intervention.
Administrators can monitor device status, connectivity, compliance, and performance metrics in real time, helping identify and resolve issues before they impact study participants. Remote support capabilities allow many problems to be addressed without requiring device replacement or patient disruption.
Because Inventus Control is integrated with Inventus hardware and connectivity services, stakeholders benefit from a single operational environment covering devices, network connectivity, logistics, and support. This provides end-to-end visibility across the entire device ecosystem, helping ensure studies remain compliant, efficient, and patient focused throughout their duration.
What makes your solution stand out in the market?
What differentiates Inventus Control is that it was built exclusively for clinical trials. While many providers offer general-purpose MDM solutions, Inventus has created a platform specifically designed around the operational, regulatory, and patient-centric requirements of clinical research.
The platform forms part of a fully integrated ecosystem that combines purpose-built clinical trial devices, global connectivity, logistics, lifecycle management, and support services. This enables sponsors and CROs to work with a single trusted partner, rather than coordinating multiple vendors across different functions.
Inventus Control also benefits from the experience gained through supporting more than 1,000 clinical trials across over 80 countries and 586 languages and dialects. This global experience has shaped a platform capable of operating at scale while maintaining simplicity for users worldwide.
About Inventus
Inventus is the world’s only company dedicated to creating bespoke technology solutions designed exclusively for clinical trials. As a global technology solutions leader, Inventus is pioneering the delivery of smarter, more efficient trials while always thinking about the patient and site experience. Working in partnership with the world’s largest pharmaceutical companies, eCOA partners, technology vendors, and the wider DCT and DHT ecosystem, Inventus’ technology solutions provide participants with confidence that their data is secure and that their experience from start to finish will be seamless and efficient. Over the last six years, Inventus has deployed 550,000 devices which have been used in more than 1,000 clinical trials across a multitude of therapeutic areas and countries, with support for 586 languages. This means anyone, anywhere in the world, can use its solutions with ease. Inventus is at the forefront in delivering preventative health technology solutions while driving clinical trials through connected technologies and fully sustainable device programmes that ensure zero waste.
